Health & Fitness
Health and Fitness
Health and Fitness 
Mon, April 25, 2011
Sun, April 24, 2011
Sat, April 23, 2011
Fri, April 22, 2011
Thu, April 21, 2011
Exelixis Announces May 3rd Webcast of Its First Quarter 2011 Financial Results Conference Call
SOUTH SAN FRANCISCO, Calif.--([ BUSINESS WIRE ])--Exelixis, Inc. (NASDAQ: EXEL) will release its first quarter 2011 financial results on Tuesday, May 3, 2011, after the markets close. The announcement will be followed by a live webcast at 5:00 p.m. EDT/ 2:00 p.m. PDT. During the webcast, Exelixis management will discuss the companya™s financial results, 2011 financial guidance, corporate strategy, and provide a general business update. The webcast may be accessed in the Event Calendar page under Investors and Media at [ www.exelixis.com ].
An archived replay of the webcast will be available on the Event Calendar page under Investors and Media at [ www.exelixis.com ] and via phone until 11:59 p.m. EDT on June 3, 2011. Access numbers for the phone replay are: 888-286-8010 (domestic) and 617-801-6888 (international); the passcode is 67033533.
About Exelixis
Exelixis, Inc. is a biotechnology company committed to developing small molecule therapeutics for the treatment of cancer. Exelixis is focusing its resources and development efforts exclusively on cabozantinib, its most advanced solely-owned product candidate, in order to maximize the therapeutic and commercial potential of this compound. Exelixis believes cabozantinib has the potential to be a high-quality, differentiated pharmaceutical product that can make a meaningful difference in the lives of patients. Exelixis has also established a portfolio of other novel compounds that it believes have the potential to address serious unmet medical needs. For more information, please visit the companya™s web site at [ www.exelixis.com ].